Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ICG Visualization in Bariatric Surgery
NCT06002906Phase 4Active, not recruiting
- Sponsor
- University Health Network
- Start
- Jan 2023
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of indocyanine green in class III obesity and gastric ulcer, sponsored by University Health Network. Primary endpoint: The applicability of ICG as an indicator of anastomotic blood flow during bariatric surgery at 2 years. Started Jan 2023; status: active, not recruiting.
02
Drugs
indocyanine green
03
Conditions
class III obesitygastric ulcer
Beyond the preview
Go deeper on NCT06002906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06002906.